Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Drug discovery of histone lysine demethylases (KDMs) inhibitors (progress from 2018 to present)
Xingrui He, Hang Zhang, Yingqian Zhang, et al.
European Journal of Medicinal Chemistry (2022) Vol. 231, pp. 114143-114143
Closed Access | Times Cited: 17

Showing 17 citing articles:

The roles of histone modifications in tumorigenesis and associated inhibitors in cancer therapy
Yunkai Yang, Min Zhang, Yan Wang
Journal of the National Cancer Center (2022) Vol. 2, Iss. 4, pp. 277-290
Open Access | Times Cited: 53
Histone demethylases in the regulation of immunity and inflammation
Lihua Qu, Tong Yin, Yijin Zhao, et al.
Cell Death Discovery (2023) Vol. 9, Iss. 1
Open Access | Times Cited: 26
Advances in Integrated Multi-omics Analysis for Drug-Target Identification
Peiling Du, Rui Fan, Nana Zhang, et al.
Biomolecules (2024) Vol. 14, Iss. 6, pp. 692-692
Open Access | Times Cited: 11
Chemical Inhibitors Targeting the Histone Lysine Demethylase Families with Potential for Drug Discovery
Nando Dulal Das, Hideaki Niwa, Takashi Umehara
Epigenomes (2023) Vol. 7, Iss. 1, pp. 7-7
Open Access | Times Cited: 13
Non-oncogene dependencies: Novel opportunities for cancer therapy
Tiziana Di Marco, Mara Mazzoni, Angela Greco, et al.
Biochemical Pharmacology (2024) Vol. 228, pp. 116254-116254
Closed Access | Times Cited: 3
The role of artificial intelligence in drug screening, drug design, and clinical trials
Yaojiong Wu, Li Ma, Xinyi Li, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 2
A Live-Cell Epigenome Manipulation by Photo-stimuli-responsive Histone Methyltransferase Inhibitor
Chuan-Shuo Wu, Xin Sun, Li Liu, et al.
(2024)
Open Access | Times Cited: 1
Mining the Dynamical Properties of Substrate and FAD Binding Pockets of LSD1: Hints for New Inhibitor Design Direction
Kecheng Yang, Hong‐Min Liu
Journal of Chemical Information and Modeling (2024) Vol. 64, Iss. 12, pp. 4773-4780
Closed Access | Times Cited: 1
Uncovering New Conformational States of the Substrate Binding Pocket of LSD1 Potential for Inhibitor Design via Funnel Metadynamics
Kecheng Yang, Hong‐Min Liu
The Journal of Physical Chemistry B (2023) Vol. 128, Iss. 1, pp. 137-149
Closed Access | Times Cited: 3
Universal Strategy to Develop Fluorogenic Probes for Lysine Deacylase/Demethylase Activity and Application in Discriminating Demethylation States
Wenyu Wei, Jie Zhang, Zhiqiang Xu, et al.
ACS Sensors (2023) Vol. 8, Iss. 1, pp. 28-39
Closed Access | Times Cited: 2
Histone Demethylase Modulation: Epigenetic Strategy to Combat Cancer Progression
Rashmi Srivastava, Rubi Singh, Shaurya Jauhari, et al.
Epigenomes (2023) Vol. 7, Iss. 2, pp. 10-10
Open Access | Times Cited: 2
A Live‐Cell Epigenome Manipulation by Photo‐Stimuli‐Responsive Histone Methyltransferase Inhibitor
Chuan‐Shuo Wu, Xin Sun, Li Liu, et al.
Advanced Science (2024)
Open Access
KDM2A plays a dual role in regulating the expression of malignancy-related genes in esophageal squamous cell carcinoma
Jian Wang, Zhiya Zhang, Jie Jiang, et al.
Biochemical and Biophysical Research Communications (2022) Vol. 624, pp. 53-58
Closed Access | Times Cited: 3
Comprehensive analysis of histone methylation modification regulators for predicting prognosis and drug sensitivity in lung adenocarcinoma
Ying Ye, Li Li, Qinjin Dai, et al.
Frontiers in Cell and Developmental Biology (2022) Vol. 10
Open Access | Times Cited: 3
Anti-Proliferative Effect of Potential LSD1/CoREST Inhibitors Based on Molecular Dynamics Model for Treatment of SH-SY5Y Neuroblastoma Cancer Cell Line
Hiba Zalloum, Waleed A. Zalloum, Tareq Hameduh, et al.
Asian Pacific Journal of Cancer Prevention (2022) Vol. 23, Iss. 10, pp. 3533-3540
Open Access | Times Cited: 1
Synthesis andin silicostudy of 2,4-diphenylquinolines as potential KDM4B protein inhibitors
Dayana Orosco, Gustavo Adolfo Barraza, Carlos E. Puerto Galvis, et al.
New Journal of Chemistry (2023) Vol. 47, Iss. 35, pp. 16518-16530
Closed Access
Anti-proliferative effect of potential LSD1/CoREST inhibitors based on molecular dynamics model for treatment of SH-SY5Y neuroblastoma cancer cell line
Hiba Zalloum, Waleed A. Zalloum, Tareq Hameduh, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access
Page 1

Scroll to top